Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > GOOD READ!
View:
Post by FREEDOM55 on Apr 21, 2021 10:18am

GOOD READ!

https://www.the-scientist.com/news-opinion/covid-19-diagnostics-how-do-saliva-tests-compare-to-swabs--68035
Comment by Smokey1958 on Apr 21, 2021 10:59am
To add to the reading list, thanks Freedom! This study was carried out in January of 2021 and published in the The American Journal of Cardiology. I will include the link for the study that reviewed previous analysis of over 7000 samples. Their conclusion .... Sample collection through saliva or nasopharyngeal swabbing does not differ significantly in sensitivity. Salivary collection ...more  
Comment by Smokey1958 on Apr 21, 2021 11:08am
The following title for this study represents even more support for the game changing potential of AcuVid, particularly for the niche it could occupy ...which is expansive. https://www.nature.com/articles/s41598-021-82787-z   "Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection"    
Comment by stockmonster6 on Apr 21, 2021 11:40am
Thanks for these informative posts. Good reads while sitting around on isolation working virtually from home (due to travel, not illness :) ) I like the concept that the saliva tests are good for asymptomatic.  This is a key area that needs attention - to catch and slow down the transfer in people who do not appear to be sick; therefore are carriers. I would love a test like this, as I ...more  
Comment by nrv090909 on Apr 21, 2021 11:50am
Great read. I am very confident in Acuvid even more now. I think I will choose the V8 5.0 Liter Range Rover now, rather than the Ford Tauraus. Go Therma! Vroom Vroom
Comment by stockmonster6 on Apr 21, 2021 11:37am
I like those findings!
Comment by Moemoney42 on Apr 21, 2021 11:42am
I'm going to pose a question and see if any of you "scientists/geniouses" can answer it truthfully.. Seeing as how Astra Zenika's vaccine actually injects a small dose of Covid into you, will you then test positve for Covid within 14 days.. if so, whats the point of testing.. just keep running with the vaccines.. now Phizer and Moderna don't inject small doses of the actual ...more  
Comment by Hempminister on Apr 21, 2021 1:16pm
Majority of population will not be vaccinated. Hence need for tests for ever
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities